Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02957
Species: Homo sapiens
Position : chr19:15311000-15312500
Year: 2020
Title: Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: lung adenocarcinoma
PMID:  33219226
MONDO: MONDO:0005061
Tissue: lung
Tissue Ontology ID: UBERON:0002048
Cell Source: NCI-H460
CVCL ID: CVCL_0459
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Functional perturbation assay, TF binding assay
High Throughput Method: ChIP-seq; RNA-seq; ATAC-seq
Low Throughput Method: CRISPR Knockout; ChIP-RT-qPCR; RT-RT-qPCR; Western blot
About Target Gene
Target gene : NOTCH3
About TF
TF name : FOSL2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOSL2 AP-1 transcription factor network pid 71
FOSL2 Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling (JNK cascade) ) inoh 5
FOSL2 Gene expression of IL2 by AP-1 ( CD4 T cell receptor signaling ) inoh 5
FOSL2 JNK cascade ( CD4 T cell receptor signaling (JNK cascade) ) inoh 12
FOSL2 JNK cascade ( CD4 T cell receptor signaling ) inoh 10
FOSL2 Validated transcriptional targets of AP1 family members Fra1 and Fra2 pid 37
FOSL2 Validated transcriptional targets of deltaNp63 isoforms pid 47
Enhancer Associated Network
Overlapping Enhancers (hg19) 6 found
Enhancer ID Position Tissue Cell Disease
E_02954 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
E_02955 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
E_02956 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
E_02958 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
E_02959 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
E_03012 chr19:15311000-15312500 lung malignant cell lung adenocarcinoma
Expression of Target Genes for the Enhancer